Fintel reports that on October 17, 2025, B of A Securities maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...
Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...
CRISPR Therapeutics (CRSP) has filed a prospectus supplement with the U.S. SEC to sell up to $600 million worth of its common ...
Baby KJ's medical team intend to ask the FDA to start a clinical trial that would be open to patients with seven different ...
The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.
This interesting study adapts machine learning tools to analyze movements of a chromatin locus in living cells in response to serum starvation. The machine learning approach developed is useful, the ...
The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human ...
Zacks Investment Research on MSN
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
After a chorus of comics slammed the lineup of stand-ups participating in Saudi Arabia‘s Riyadh Comedy Festival, Arrested Development alum David Cross is also voicing his staunch disapproval. In a ...
As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...
Martin Jucker receives funding from the NSW Bushfire and Natural Hazards Research Centre. Right now, cold air high above Antarctica is up to 35ºC warmer than normal. Normally, strong winds and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results